Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Tavalisse (fostamatinib)
i
Other names:
R935788, R788, R788 sodium, R-985788, FosD, R406, R940406, R 985788, R-406/788, R-788, R-935/788, IMG-016, IMG016, IMG 016, R985788, R 406/788, R406/788, R 935/788, R935/788, R 935788, R-935788, R-940406, R 940406
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Grifols, Inmagene, JW Pharma, Kissei, Knight Therap, Rigel
Drug class:
SYK inhibitor
Related drugs:
‹
GS-9973 (20)
CB-659 (4)
ALXN2075 (2)
GS-9876 (2)
HM43239 (2)
BAY-61-3606 (1)
EC-70124 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
GS-9973 (20)
CB-659 (4)
ALXN2075 (2)
GS-9876 (2)
HM43239 (2)
BAY-61-3606 (1)
EC-70124 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
PTPN6 negative
Diffuse Large B Cell Lymphoma
PTPN6 negative
Diffuse Large B Cell Lymphoma
venetoclax + fostamatinib
Sensitive: D – Preclinical
venetoclax + fostamatinib
Sensitive
:
D
venetoclax + fostamatinib
Sensitive: D – Preclinical
venetoclax + fostamatinib
Sensitive
:
D
BCL2 positive
Diffuse Large B Cell Lymphoma
BCL2 positive
Diffuse Large B Cell Lymphoma
venetoclax + fostamatinib
Sensitive: D – Preclinical
venetoclax + fostamatinib
Sensitive
:
D
venetoclax + fostamatinib
Sensitive: D – Preclinical
venetoclax + fostamatinib
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login